| Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2008: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
|---|
| Research Abstract |
The worst 1 of cause of human death is infectious disease by pathogenic microorganisms. In developed countries, such as our country and countries in Europe and North America, infectious diseases by multidrug-resistant bacteria are serious problems. Many drugs used at clinical sites are not effective on the multidrug resistant bacteria. Aims of this research are to analyze multidrug resistant systems in multidrug resistant bacteria and to develop drugs effective on such resistant bacteria. In fact, we analyzed multidrug resistant systems in several multidrug resistant bacteria, and found several seed compounds effective on such multidrug resistant bacteria.
|
